Healthcare Triangle Secures $1.63 Million Through Warrant Inducement Transaction

Healthcare Triangle, Inc. has executed warrant exercise agreements with three existing accredited investors that will generate approximately $1.63 million in immediate gross proceeds for the digital transformation solutions provider. The transaction involves the full exercise of 812,775 outstanding warrants at a reduced price of $2.00 per share, down significantly from the original $20.92 exercise price. This strategic financial maneuver provides immediate capital infusion while restructuring the company's warrant obligations.

In exchange for the immediate exercise of existing warrants, the participating investors will receive new unregistered warrants to purchase up to 812,775 shares of common stock at $3.00 per share. These new warrants become exercisable upon obtaining stockholder approval and will remain valid for five years from that approval date. The transaction represents a carefully structured approach to capital raising that balances immediate funding needs with future equity considerations.

The warrant inducement transaction, expected to close on October 2, 2025, demonstrates Healthcare Triangle's proactive approach to strengthening its financial position. WallachBeth Capital is serving as the sole placement agent for this transaction, bringing specialized expertise in navigating complex financial arrangements. The $1.63 million in gross proceeds excludes potential future revenue from the exercise of new warrants and precedes the deduction of placement agent fees and other offering expenses.

This capital infusion comes at a critical time for healthcare technology companies facing increasing demands for digital transformation solutions. Healthcare Triangle specializes in supporting healthcare organizations including hospitals, health systems, payers, and pharmaceutical companies through their digital transformation platform. The company's achievement of HITRUST Certification for Cloud and Data Platform underscores its commitment to maintaining the highest standards for data protection and information security in the heavily regulated healthcare sector.

The immediate financial impact of this transaction provides Healthcare Triangle with additional resources to accelerate its strategic initiatives in cloud services, security and compliance, data lifecycle management, and healthcare interoperability. For investors and industry observers, this warrant restructuring signals management's confidence in the company's growth trajectory and its ability to navigate the complex regulatory environment governing healthcare technology. The transaction structure also reflects sophisticated financial engineering aimed at optimizing capital structure while maintaining alignment with existing investors' interests.

As healthcare organizations increasingly rely on digital solutions to improve patient outcomes and operational efficiency, Healthcare Triangle's strengthened financial position enables continued investment in the technologies and expertise required to meet evolving industry demands. The company's focus on enabling business agility and responding to competitive threats positions it to capitalize on the growing digital transformation market within healthcare and life sciences.